PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $41,000 | -12.8% | 13,846 | -18.7% | 0.00% | 0.0% |
Q4 2017 | $47,000 | -19.0% | 17,029 | 0.0% | 0.00% | -33.3% |
Q3 2017 | $58,000 | +52.6% | 17,029 | +48.7% | 0.00% | +50.0% |
Q3 2016 | $38,000 | -2.6% | 11,453 | -6.7% | 0.00% | 0.0% |
Q2 2016 | $39,000 | -20.4% | 12,275 | -17.3% | 0.00% | 0.0% |
Q1 2016 | $49,000 | -29.0% | 14,849 | -24.0% | 0.00% | -33.3% |
Q4 2015 | $69,000 | – | 19,550 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |